Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ERIC 2022 | Obstacles to achieving a cure in CLL

Nicholas Chiorazzi, MD, Feinstein Institute for Medical Research, Manhasset, NY, discusses the possibility of achieving a cure in chronic lymphocytic leukemia (CLL). Whilst novel agents have been shown to lead to long-term remissions, it is critical to better manage side effects as it is an important cause for treatment discontinuation. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.